E

Evrofarma SA
ATHEX:EVROF

Watchlist Manager
Evrofarma SA
ATHEX:EVROF
Watchlist
Price: 1.41 EUR 2.17% Market Closed
Market Cap: 19.3m EUR
Have any thoughts about
Evrofarma SA?
Write Note

Intrinsic Value

The intrinsic value of one EVROF stock under the Base Case scenario is 1.99 EUR. Compared to the current market price of 1.41 EUR, Evrofarma SA is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EVROF Intrinsic Value
1.99 EUR
Undervaluation 29%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation Backtest
Evrofarma SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EVROF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EVROF?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Evrofarma SA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Evrofarma SA

Provide an overview of the primary business activities
of Evrofarma SA.

What unique competitive advantages
does Evrofarma SA hold over its rivals?

What risks and challenges
does Evrofarma SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Evrofarma SA.

Provide P/S
for Evrofarma SA.

Provide P/E
for Evrofarma SA.

Provide P/OCF
for Evrofarma SA.

Provide P/FCFE
for Evrofarma SA.

Provide P/B
for Evrofarma SA.

Provide EV/S
for Evrofarma SA.

Provide EV/GP
for Evrofarma SA.

Provide EV/EBITDA
for Evrofarma SA.

Provide EV/EBIT
for Evrofarma SA.

Provide EV/OCF
for Evrofarma SA.

Provide EV/FCFF
for Evrofarma SA.

Provide EV/IC
for Evrofarma SA.

Compare the intrinsic valuations
of Evrofarma SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Evrofarma SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Evrofarma SA compared to its peers.

Compare the P/E ratios
of Evrofarma SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Evrofarma SA with its peers.

Analyze the financial leverage
of Evrofarma SA compared to its main competitors.

Show all profitability ratios
for Evrofarma SA.

Provide ROE
for Evrofarma SA.

Provide ROA
for Evrofarma SA.

Provide ROIC
for Evrofarma SA.

Provide ROCE
for Evrofarma SA.

Provide Gross Margin
for Evrofarma SA.

Provide Operating Margin
for Evrofarma SA.

Provide Net Margin
for Evrofarma SA.

Provide FCF Margin
for Evrofarma SA.

Show all solvency ratios
for Evrofarma SA.

Provide D/E Ratio
for Evrofarma SA.

Provide D/A Ratio
for Evrofarma SA.

Provide Interest Coverage Ratio
for Evrofarma SA.

Provide Altman Z-Score Ratio
for Evrofarma SA.

Provide Quick Ratio
for Evrofarma SA.

Provide Current Ratio
for Evrofarma SA.

Provide Cash Ratio
for Evrofarma SA.

What is the historical Revenue growth
over the last 5 years for Evrofarma SA?

What is the historical Net Income growth
over the last 5 years for Evrofarma SA?

What is the current Free Cash Flow
of Evrofarma SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Evrofarma SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Evrofarma SA

Current Assets 19m
Cash & Short-Term Investments 470k
Receivables 9.7m
Other Current Assets 8.9m
Non-Current Assets 30.5m
Long-Term Investments 622k
PP&E 29.9m
Intangibles 33k
Other Non-Current Assets 25k
Current Liabilities 13.8m
Accounts Payable 6.8m
Short-Term Debt 3.3m
Other Current Liabilities 3.7m
Non-Current Liabilities 18.1m
Long-Term Debt 11m
Other Non-Current Liabilities 7.1m
Efficiency

Earnings Waterfall
Evrofarma SA

Revenue
46.8m EUR
Cost of Revenue
-31.1m EUR
Gross Profit
15.7m EUR
Operating Expenses
-11.6m EUR
Operating Income
4.1m EUR
Other Expenses
-1.9m EUR
Net Income
2.2m EUR

Free Cash Flow Analysis
Evrofarma SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EVROF Profitability Score
Profitability Due Diligence

Evrofarma SA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
ROIC is Increasing
ROE is Increasing
49/100
Profitability
Score

Evrofarma SA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

EVROF Solvency Score
Solvency Due Diligence

Evrofarma SA's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
36/100
Solvency
Score

Evrofarma SA's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EVROF Price Targets Summary
Evrofarma SA

There are no price targets for EVROF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EVROF?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EVROF is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Evrofarma SA

Country

Greece

Industry

Food Products

Market Cap

19.3m EUR

Dividend Yield

0%

Description

Evrofarma SA engages in the production of milk and dairy products. The firm offers five ranges of products: Milk, including fresh whole, semi-skimmed and skimmed milk, highly pasteurized milk and chocolate flavored milk; the traditional Ariani Milk Drink, available also with added flavors; Yogurt, including traditional, cow-milk and strained yogurt; Milk Cream, as well as Cheese, such as goat, feta and organic feta cheese and anthotiro. The company also supplies the yellow cheeses of Doiranis brand, including traditional kasseri and semi-hard cheeses. The Company’s milk supplies come from various farmers and associates in Macedonia and Thrace. Its production facilities cover 10,000 square meters and it has four distribution centers in Northern Greece, as well as a fleet of privately owned trucks that distribute its products in more than 3,000 points of sale locations. Evrofarma SA has a wholly owned subsidiary, Campus SA, which deals mainly with milk production.

Contact

EASTERN MACEDONIA AND THRACE
1st km Didimoticho - Orestiada, Didymoteicho
+302553020020
www.evrofarma.gr

IPO

2000-06-12

Employees

-

Officers

Chairman & CEO
Mr. Paschalis H. Papazilakis
Deputy President & Executive Director
Mr. Christos Papazilakis
Executive Director
Mr. Panagiotis Papazilakis

See Also

Discover More
What is the Intrinsic Value of one EVROF stock?

The intrinsic value of one EVROF stock under the Base Case scenario is 1.99 EUR.

Is EVROF stock undervalued or overvalued?

Compared to the current market price of 1.41 EUR, Evrofarma SA is Undervalued by 29%.

Back to Top